Samsung Biologics strike enters work-to-rule phase amid deadlocked talks

A five-day strike at Samsung Biologics, running through Tuesday, is set to enter a new phase Wednesday, with the rift between labor and management exhibiting no signs of narrowing. Organized by the firm's labor union — the first such action in 15 years — the general walkout has involved workers taking paid leave and refusing weekend shifts in lieu of mass rallies. Some 2,800 workers -- more than half the company's workforce -- have taken part. The union said that once the full strike concludes,

By The Korea Herald